MedPath

Can people with substance misuse and depression benefit from brief psychological therapies?

Not Applicable
Completed
Conditions
Mild to moderate substance misuse and depression
Mental and Behavioural Disorders
Depressive episode, unspecified
Registration Number
ISRCTN26937594
Lead Sponsor
HS Leeds (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Are currently engaging with a community drugs treatment, detox, maintenance or addiction recovery focused service in Leeds. Engagement is defined by:
1.1. Being currently registered with a formal addiction focused service or programme
1.2. Having had planned contact with the service within the last month
2. Meet criteria for a current depressive disorder as defined by a score of 12 or more on the PHQ-9 questionniare. Comorbid anxiety disorders are not exclusion criteria, as long as depression is the primary disorder
3. Meet criteria for mild-to-moderate severity of drug dependence, as defined by a score between 0 ? 10 on the Severity of Dependence Questionnaire
4. Have used alcohol, drugs, or methadone maintenance medication within the last month

Exclusion Criteria

1. Are not currently engaging in a formal addiction treatment or support programme in Leeds
2. Do not currently meet criteria as clinically significant for depressive disorder as defined by the PHQ-9 questionnaire score
3. Meet criteria for depression and a comorbid anxiety disorder, as identified by the GAD-7 questionnaire. Where the anxiety disorder is more severe, has been of longer duration than depressive symptoms and is the patient's main concern.
4. Meet criteria for a severe mental disorder including bipolar affective disorder, schizophrenia or other psychotic disorders. Patients with severe mental health problems who are already involved in psychiatric or secondary care mental health services.
5. Are free of substances of dependence and/or maintained on disulfiram, acamprosate or naloxone.
6. Those who have a severe drug or alcohol dependence, as defined by a score above 10 on the Severity of Dependence Questionnaire.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath